Recall Radar
All recallsMedicine & devices

Duloxetine Delayed-Release Capsules USP, 60mg, Rx Only, 90-count bottle, Mfr. by Towa Pharmaceutical Eurpoe S.L., Martorelles, (Barcelona), Spain, Dist. by. Breckenridge Pharmaceu…

CGMP Deviations; presence of N-nitroso-duloxetine impurity above the FDA recommended limit

Class II Medicine & devices FDA May 13, 2026 Reached Texas
Read the official FDA notice →

What to do

Stop using the product and check it against the description above. Follow the remedy on the official notice; most recalls are refunded or replaced without a receipt. If you or a family member has already been affected, keep the packaging and the lot code — they're what a claim rests on later.

Details

Recalling company
Breckenridge Pharmaceutical, Inc. — Berkeley Heights, NJ
Severity
Class II — moderate
Reported
May 13, 2026
Quantity
165,761 90-count bottles
Recall number
D-0522-2026
Status
Ongoing
Source
FDA

Where it went

Nationwide in the USA

Other medicine & devices recalls

See every current recall on the live dashboard →